Invesco Variable Rate Investment Grade ETF analysis: ultra-low duration, 4.8% SEC yield, ~100 bps over T-bills, and strong ...

Inspire 500 ETF review: faith-based screens add a quality cost. Inspire screens for "violations" and "excellence". Read here ...

Deutsche Telekom looks overvalued vs. fundamentals, keeping risk elevated. Read here for a detailed investment details of ...

YieldMax's CHPY ETF beats the S&P 500 with 31% growth since April 2025, driven by semiconductors and strong distributions.

Healthpeak Properties (DOC) benefits from South San Francisco life-science demand and stable outpatient cash flow. See more ...

Calumet (CLMT) poised for big EBITDA growth through 2026–2028 as SAF margins expand and ops improve. Read here for more ...

AI, electrification & smart manufacturing tailwinds plus vacuum recovery and resilient service revenue. See more details here ...

Lionsgate (LION) stock was downgraded to sell after Q2 revenue plunged 42% y/y, leverage hit 6.5x, and valuation stretched.

After five days of gains, oil prices came under significant pressure yesterday, with ICE Brent settling 4.15% lower.

SPDR S&P Regional Banking ETF (KRE) analysis: diversified regional bank exposure, CRE risk. Sector metrics show resilient net income and NIM recovery. See more.

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Shares MSCI Australia ETF (EWA) outlook: strong 1-year return but lags peers. EWA is close to hitting multi-year resistances.